Analysis of HER2 Gene Amplification Using an Automated Fluorescence in Situ Hybridization Signal Enumeration System
Authors:
- Imad AlmanaseerIAImad Almanaseer
- Miguel GonzalezMGMiguel Gonzalez
- Derin CaglarDCDerin Caglar
- Ryan A. KnudsonRKRyan A. Knudson
- Rhett P. KetterlingRKRhett P. Ketterling
- Daniel S. SchrockDSDaniel S. Schrock
- Thomas A. SeemayerTSThomas A. Seemayer
- Julia A. BridgeJBJulia A. Bridge
- 1 April 2007
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 9 (2) , 144-150
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Determination of HER2 Gene Amplification by Fluorescence In situ Hybridization and Concordance with the Clinical Trials Immunohistochemical Assay in Women with Metastatic Breast Cancer Evaluated for Treatment with TrastuzumabBreast Cancer Research and Treatment, 2005
- HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniquesJournal of Clinical Pathology, 2005
- Detection and Quantitation of HER-2 Gene Amplification and Protein Expression in Breast CarcinomaAmerican Journal of Clinical Pathology, 2004
- Detection and Quantitation of HER-2 Gene Amplification and Protein Expression in Breast CarcinomaAmerican Journal of Clinical Pathology, 2004
- HER-2 Testing in Breast Cancer Using Immunohistochemical Analysis and Fluorescence In Situ Hybridization : A Single-Institution Experience of 2,279 Cases and Comparison of Dual-Color and Single-Color ScoringAmerican Journal of Clinical Pathology, 2004
- Enhanced Accuracy and Reliability of HER-2/neu Immunohistochemical Scoring Using Digital MicroscopyAmerican Journal of Clinical Pathology, 2004
- Comparative multi‐methodological measurement of ERBB2 status in breast cancerThe Journal of Pathology, 2004
- Automatic quantification of gene amplification in clinical samples by IQ‐FISHCytometry Part B: Clinical Cytometry, 2003
- HER2 Testing in Patients With Breast Cancer: Poor Correlation Between Weak Positivity by Immunohistochemistry and Gene Amplification by Fluorescence In Situ HybridizationMayo Clinic Proceedings, 2002
- Testing for HER2 StatusOncology, 2001